Clinical Trial Update: Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

A Phase I trial of HRS-7053 injection for advanced cancer has been withdrawn; no results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HRS-7053 injection (HRS-7053)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Malignant Cancer | Phase 1 | Status: WITHDRAWN